We are live on ! Find out more
CVRS

CORINDUS VASCULAR ROBOTICS, INC
CVRS

Delisted

CVRS was delisted on the 28th of October, 2019.

70 hedge funds and large institutions have $85.4M invested in CORINDUS VASCULAR ROBOTICS, INC in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

35% more capital invested

Capital invested by funds: $63.2M → $85.4M (+$22.2M)

28% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 18

9% more funds holding

Funds holding: 6470 (+6)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
70
Holders Change
+6
Holders Change %
+9.38%
% of All Funds
1.6%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
23
Reduced
18
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
HM
1
HealthCor Management
New York
$27.4M
HEC
2
Hudson Executive Capital
New York
$15.5M
Fidelity Investments
3
Fidelity Investments
Massachusetts
$8.65M
CCM
4
Consonance Capital Management
New York
$6.27M -$1.64M -1,411,170 -24%
BlackRock
5
BlackRock
New York
$6.03M +$17.1K +14,735 +0.3%
Vanguard Group
6
Vanguard Group
Pennsylvania
$5.57M +$174K +149,530 +4%
Millennium Management
7
Millennium Management
New York
$3.35M +$322K +277,336 +13%
EIM
8
Essex Investment Management
Massachusetts
$1.6M -$78.2K -67,384 -5%
State Street
9
State Street
Massachusetts
$1.6M +$38.1K +32,840 +3%
Northern Trust
10
Northern Trust
Illinois
$1.45M -$48.8K -41,998 -4%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$1.09M +$19.6K +16,897 +2%
FHAM
12
Folger Hill Asset Management
New York
$891K +$755K +650,000 New
PVAM
13
Pacific View Asset Management
California
$811K +$171K +147,246 +33%
BCM
14
Bridgeway Capital Management
Texas
$628K +$67.6K +58,200 +15%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$408K +$36K +30,976 +12%
TCIM
16
TIAA CREF Investment Management
New York
$365K -$15.4K -13,253 -5%
Morgan Stanley
17
Morgan Stanley
New York
$298K -$2.5K -2,154 -1%
MIFH
18
Migdal Insurance & Financial Holdings
Israel
$295K +$250K +214,980 New
Charles Schwab
19
Charles Schwab
California
$289K
US Bancorp
20
US Bancorp
Minnesota
$275K
TA
21
Teachers Advisors
New York
$256K +$16.9K +14,564 +8%
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$220K
Deutsche Bank
23
Deutsche Bank
Germany
$216K -$106K -91,120 -36%
WAM
24
Wealthspire Advisors (Maryland)
Maryland
$161K +$137K +117,875 New
PCM
25
Prelude Capital Management
New York
$144K

CVRS Hedge Fund Activity: Q1 2018 in Review

70 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in CORINDUS VASCULAR ROBOTICS, INC (CVRS) for Q1 2018, worth a combined $85.4M — up 35% from $63.2M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CVRS positions and 4 closed out — a net gain of 6 holders — while 23 added to existing stakes and 18 trimmed.

The largest buyer was Folger Hill Asset Management, opening a new position worth an estimated $755K. The largest seller was Consonance Capital Management, cutting an estimated $1.64M.

  • 70 institutional investors held CORINDUS VASCULAR ROBOTICS, INC (CVRS) as of Q1 2018, up from 64 in Q4 2017.
  • Funds reported $85.4M of CORINDUS VASCULAR ROBOTICS, INC stock for Q1 2018, up 35% quarter-over-quarter.
  • 10 funds opened new CORINDUS VASCULAR ROBOTICS, INC positions in Q1 2018 and 4 closed out, a net change of +6 holders.
  • The largest CORINDUS VASCULAR ROBOTICS, INC buyer in Q1 2018 was Folger Hill Asset Management, an estimated $755K added.
  • The largest CORINDUS VASCULAR ROBOTICS, INC seller in Q1 2018 was Consonance Capital Management, an estimated $1.64M sold.

Based on aggregated 13F filings for Q1 2018.